Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/14/2010CA2757646A1 Method of predicting a predisposition to qt prolongation based on bai3 gene sequence or product thereof
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757574A1 Inhibitors of bacterial type iii secretion system
10/14/2010CA2757466A1 Pharmaceutical composition for treating or preventing burn injuries
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2757327A1 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
10/14/2010CA2757310A1 Stable pharmaceutical compositions of diclofenac
10/14/2010CA2757269A1 Hepatitis c virus inhibitors
10/14/2010CA2757241A1 Solid state forms of sitagliptin salts
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010CA2756727A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
10/14/2010CA2756568A1 Kinase inhibitors and method of treating cancer with same
10/14/2010CA2756542A1 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
10/14/2010CA2756272A1 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
10/14/2010CA2756250A1 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
10/14/2010CA2756104A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010CA2755918A1 Oxadiazole derivatives
10/14/2010CA2755789A1 Treatment regimen utilizing neratinib for breast cancer
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/14/2010CA2755171A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
10/14/2010CA2754828A1 Method for preparing molecular complexes between adapalene and cyclodextrins
10/14/2010CA2754412A1 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjogren's syndrome
10/14/2010CA2754343A1 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis
10/14/2010CA2753151A1 Substituted piperidines as ccr3 antagonists
10/14/2010CA2750626A1 High dosage doramectin formulation
10/14/2010CA2749253A1 Once-daily oral ir/cr pramipexole formulation
10/13/2010EP2239674A1 Method for classifying and treating physiologic brain imbalances using quantitative EEG
10/13/2010EP2239265A1 Crystalline cinnamide compounds or salts thereof
10/13/2010EP2239264A1 Antitumor agent
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2239261A1 Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof
10/13/2010EP2239254A1 Benzylpiperizine compound
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2239251A1 Process for refining 2-aminoethanesulfonic acid from crude 2-aminoethane-sulfonic acid, 2-aminoethanesulfonic acid obtained there from and use thereof
10/13/2010EP2239012A2 Pharmaceutical use of substituted amides
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238982A2 Therapeutic agent for soft tissue sarcoma
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2238979A1 Active pharmaceutical ingredient adsorbed on solid support
10/13/2010EP2238978A1 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence
10/13/2010EP2238977A2 Skin cleaning products
10/13/2010EP2238976A1 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
10/13/2010EP2238975A1 Gastric retention controlled drug delivery system
10/13/2010EP2238973A1 Lyophilized preparations of proteasome inhibitors
10/13/2010EP2238970A1 Emulsion preparation for external application to skin and cosmetic preparation
10/13/2010EP2238969A1 Preparation for external application to skin and cosmetic preparation
10/13/2010EP2238251A1 Silencing of polo-like kinase expression using interfering rna
10/13/2010EP2238151A1 17-hydroxy-19-nor-21-carboxylic acid-steroid -lactone derivative, use thereof, and medicament containing the derivative
10/13/2010EP2238150A1 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID y-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE
10/13/2010EP2238149A2 19-nor-steroid derivatives with a 15 ,16 -methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
10/13/2010EP2238148A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
10/13/2010EP2238147A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
10/13/2010EP2238144A1 Compounds comprising a cyclobutoxy group
10/13/2010EP2238142A2 Macrocyclic indoles as hepatitis c virus inhibitors
10/13/2010EP2238141A1 Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta
10/13/2010EP2238140A2 Substituted heteroarylamide diazepinopyrimidone derivatives
10/13/2010EP2238138A1 Tricyclic nitrogen compounds and their use as antibacterial agents
10/13/2010EP2238137A1 Compounds and compositions as kinase inhibitors
10/13/2010EP2238136A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist
10/13/2010EP2238135A1 Naphthyridin-2(1h) -one compounds useful as antibacterials
10/13/2010EP2238134A2 Bis-thiazole derivatives, process for their preparation and their use as medicaments
10/13/2010EP2238131A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
10/13/2010EP2238130A1 Carboxamide compounds and their use as calpain inhibitors
10/13/2010EP2238128A2 Heterocyclic pyrazole-carboxamides as p2y12 antagonists
10/13/2010EP2238127A2 Pyrazole-carboxamide derivatives as p2y12 antagonists
10/13/2010EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
10/13/2010EP2238125A1 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
10/13/2010EP2238122A1 Preparation of sulfamide derivatives
10/13/2010EP2238119A1 Quinazolines and related heterocyclic compounds, and their therapeutic use
10/13/2010EP2238118A1 Method of synthesis of bosentan, its polymorphic forms and its salts
10/13/2010EP2238117A1 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/13/2010EP2238116A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238115A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238114A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238113A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence
10/13/2010EP2238111A1 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of -secretase (bace)
10/13/2010EP2238110A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/13/2010EP2238108A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
10/13/2010EP2238103A1 Novel n-(2-amino-phenyl)-amide derivatives
10/13/2010EP2238101A2 Difluorobiphenylamide derivatives for the treatment of ocular hypertension
10/13/2010EP2237837A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/13/2010EP2237786A2 Use of inhibitors of connexin43 for treatment of fibrotic conditions
10/13/2010EP2237785A2 Triarylmethane analogs and their use in treating cancers
10/13/2010EP2237784A1 Activators of executioner procaspases 3, 6 and 7
10/13/2010EP2237783A1 Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit with imatinib
10/13/2010EP2237782A1 Use of tetrahydropyrimidines
10/13/2010EP2237780A1 Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives
10/13/2010EP2237779A1 Benzothiazole and benzoxazole derivatives and methods of use
10/13/2010EP2237777A2 Compositions and methods for treating neurodegenerative diseases
10/13/2010EP2237776A2 Compositions and methods for improving cardiovascular health
10/13/2010EP2237775A1 Composition for topical use
10/13/2010EP2237774A1 The use of 6-halogeno-ý1,2,4¨-triazolo-ý1,5-a¨-pyrimidine compounds for combating pests in and on animals
10/13/2010EP2237769A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals
10/13/2010EP2237768A2 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/13/2010EP2237767A1 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
10/13/2010EP2237684A2 Agonists for antimicrobial peptide systems
10/13/2010EP2237667A1 Hcv protease inhibitors and uses thereof
10/13/2010EP2237666A1 Hcv protease inhibitors and uses thereof
10/13/2010EP2237664A1 (HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
1 ... 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 ... 7860